Kenneth Bahk, PhD

Prior to Three Lakes Partners, an impact investment fund focused on improving the lives of those with IPF, Ken has served in key investment and management roles for over $1B in exits. He has also served in leadership positions for professional organizations including the American Association for Clinical Chemistry, Association for Molecular Pathology and the American Society for Microbiology. Serving as a conduit between technology and finance, Ken co-founded and manages the premier Analyst events for molecular diagnostics and microbiology to highlight technologies and approaches most likely to be relevant, impactful and commercially successful. Ken received his PhD in Biochemistry and Molecular Biology and an MS in Neurobiology and Physiology from Northwestern University, and his MBA from the Kellogg School of Management.